Cart
sales@molnova.com
ML092
CAS No. 1199523-24-4
ML092( —— )
Catalog No. M19329 CAS No. 1199523-24-4
Cruzain-IN-1 is a covalent and reversible Cruzain inhibitor (IC50: 10 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 76 | In Stock |
|
| 5MG | 69 | In Stock |
|
| 10MG | 107 | In Stock |
|
| 25MG | 210 | In Stock |
|
| 50MG | 312 | In Stock |
|
| 100MG | 439 | In Stock |
|
| 200MG | 613 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameML092
-
NoteResearch use only, not for human use.
-
Brief DescriptionCruzain-IN-1 is a covalent and reversible Cruzain inhibitor (IC50: 10 nM).
-
DescriptionCruzain-IN-1 is a covalent and reversible Cruzain inhibitor (IC50: 10 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCruzain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1199523-24-4
-
Formula Weight300.27
-
Molecular FormulaC14H10F2N6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (83.26 mM)
-
SMILESCCN1C=NC2=C1N=C(N=C2NC1=CC(F)=CC(F)=C1)C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lee GM, et al. Mapping inhibitor binding modes on an active cysteine protease via nuclear magnetic resonance spectroscopy. Biochemistry. 2012 Dec 18;51(50):10087-98.
molnova catalog
related products
-
BT44
BT44 is a novel, second-generation glial cell linederived neurotropic factor mimetic with improved biological activity and is a lead compound for the treatment of neurodegenerative disorders.
-
Arundic Acid
Arundic Acid is an astrocyte-modulating agent, delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis.
-
R-E-D-V
REDV is the minimal active sequence within the CS5 site of the alternatively spliced type III connecting segment (IIICS) region of fibronectin. REDV can mediate adhesion to the IIICS region of plasma fibronectin by binding the integrin alpha 4 beta 1(α4β1). REDV can be used for the research of cell adhesion.
